Видео ютуба по тегу Mll Rearrangement

Understanding Acute Myeloid Leukemia with KMT2A Rearrangement: A Comprehensive Guide
Understanding Acute Myeloid Leukemia with KMT2A Rearrangement: A Comprehensive Guide
MLL-rearranged acute lymphoblastic leukaemia
MLL-rearranged acute lymphoblastic leukaemia
Chromosomal Translocation and Mixed Lineage Leukemia
Chromosomal Translocation and Mixed Lineage Leukemia
Management of MLL-rearranged ALL
Management of MLL-rearranged ALL
Future directions for MLL therapy
Future directions for MLL therapy
Epigenetic Drivers of Leukemias
Epigenetic Drivers of Leukemias
Development of novel menin-MLL inhibitors for acute leukemias
Development of novel menin-MLL inhibitors for acute leukemias
Dr. Rolf Marschalek: “MLL/KMT2A leukemia - insights into the disease pathology”
Dr. Rolf Marschalek: “MLL/KMT2A leukemia - insights into the disease pathology”
Research into the management of MLL
Research into the management of MLL
Updates on the survival rates of MLL treatments
Updates on the survival rates of MLL treatments
Bleximenib dose optimization from a Phase I trial in patients with R/R acute leukemia
Bleximenib dose optimization from a Phase I trial in patients with R/R acute leukemia
Investigating PP2A-based therapeutic strategies for KMT2A-rearranged acute leukemia
Investigating PP2A-based therapeutic strategies for KMT2A-rearranged acute leukemia
Pre-clinical activity of ziftomenib in pediatric KMT2A-rearranged ALL
Pre-clinical activity of ziftomenib in pediatric KMT2A-rearranged ALL
Dr Ammar Morad : Acute Lymphoblastic Leukemia in Infants
Dr Ammar Morad : Acute Lymphoblastic Leukemia in Infants
B-ALL with KMT2A rearrangement.
B-ALL with KMT2A rearrangement.
Reflecting on the FDA approval of revumenib for KMT2A-rearranged acute leukemia
Reflecting on the FDA approval of revumenib for KMT2A-rearranged acute leukemia
The mechanism and potential of menin inhibitors in NMP1-mutated and KMT2A-rearranged AML
The mechanism and potential of menin inhibitors in NMP1-mutated and KMT2A-rearranged AML
Infant Acute Lymphoblastic Leukemia Clinical Trial
Infant Acute Lymphoblastic Leukemia Clinical Trial